Pustular vasculitis in a patient with T-cell large granular lymphocyte proliferation and myelodysplasia. Successful treatment by ciclosporin [6]

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 893-894

  Sailler, L ^a   Joseph Hein, K ^b   Astudillo, L ^a   Madaule, S ^a   Ecoiffier, M ^a   Dahan, S ^a   Delisle, M B ^b   Arlet, P ^a  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PREDNISONE;

AGED; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE TEST; LARGE GRANULAR LYMPHOCYTE; LETTER; LYMPHOCYTE PROLIFERATION; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; PUSTULOSIS; RELAPSE; REMISSION; SKIN BIOPSY; VASCULITIS;

AGED; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTOSIS; MALE; MYELODYSPLASTIC SYNDROMES; VASCULITIS, HYPERSENSITIVITY;

EID: 0242550801     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05542.x     Document Type: Letter

References (10)

1. Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol 1979; 100: 61-8.
2. Loughran TP. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1-14.
3. Dhodapkar MV, Li CY, Lust JA et al. Clinical spectrum of clonal proliferations of T large granular lymphocytes: a T-cell clonopathy of undetermined significance. Blood 1994; 84: 1620-7.
4. Scott CS, Richards SJ, Sivakumaran M et al. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: the Yorkshire Leukaemia Group Study. Br J Haematol 1993; 83: 504-15.
5. Hamidou M, Lamy T. Proliférations chroniques à grands lymphocytes granuleux. Aspects cliniques et pathogéniques. Rev Med Interne 2001; 22: 452-9.
6. Saunthararajah Y, Molldrem JL, Rivera M et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112: 195-200.
7. Hoshino S, Oshimi K, Teramura M, Mizoguchi H. Activation via the CD3 and CD16 pathway mediates interleukin-2 dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders. Blood 1991; 78: 3232-40.
8. Loughran TP, Aprile JA, Ruscetti FW. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2 independent pathway in CD3+ large granular lymphocytes. Blood 1990; 75: 935-40.
9. Watt SM, Butler LH, Tavian M et al. Functionally defined CD164 epitopes are expressed on CD34+ cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and non hematopoietic tissues. Blood 2000; 95: 3113-24.
10. Loughran TP, Draves KE, Starkebaum G et al. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2. Blood 1987; 69: 72-8.